share_log

Mexico Welcomes Legal CBD: Xebra Brands & ICAN Pave The Way With CBD Supply Deal

Mexico Welcomes Legal CBD: Xebra Brands & ICAN Pave The Way With CBD Supply Deal

墨西哥欢迎合法的CBD:Xebra品牌和ICAN通过CBD供应协议铺平了道路
Benzinga ·  02/21 11:59

Cannabis company Xebra Brands Ltd. (OTCQB:XBRAF) (CSE:XBRA) (FSE: 9YC0) announced Wednesday it has finalized a CBD supply agreement with ICAN Green S.A. de C.V. to supply CBD isolate to Desart MX S.A. de C.V., a division of Xebra, for use in the manufacturing of legal CBD products in Mexico. This collaboration leverages ICAN's reputation as a leader in cannabis-based products across Latin America.

大麻公司Xebra Brands Ltd.(OTCQB: XBRAF)(CSE: XBRA)(FSE:9YC0)周三宣布,它已与ICAN Green S.A. de C.V. 敲定了CBD供应协议,向Xebra旗下的Desart MX S.A. de C.V. 供应CBD分离物,用于在墨西哥生产合法的CBD产品。这种合作利用了ICAN作为拉丁美洲大麻类产品领导者的声誉。

Details Of The Agreement

协议的细节

Under the terms of the agreement, ICAN will be the exclusive supplier of CBD to Desart MX for two years, with the possibility of automatic annual renewal. This collaboration marks a significant milestone for both companies and underscores their commitment to partnering with the Desart MX, a division of Xebra, the only corporation in Mexico federally approved by the COFEPRIS (Mexican FDA) to import and acquire cannabis seeds, cultivate and harvest cannabis, process and produce cannabis, and sell cannabis products with less than 1% THC, both domestically and through export.

根据协议条款,ICAN将成为Desart MX的CBD独家供应商,为期两年,并可能每年自动续订。此次合作对两家公司来说都是一个重要的里程碑,也凸显了他们对与Xebra旗下的Desart MX合作的承诺。Xebra是墨西哥联邦政府批准的唯一一家由COFEPRIS(墨西哥食品药品管理局)批准的进口和收购大麻种子、种植和收获大麻、加工和生产大麻以及在国内和通过出口销售四氢大麻酚含量低于1%的大麻产品的公司。

The agreement's commercial terms, based on a per-kilogram pricing model with discounts for larger purchases, reflect a strategic approach to market penetration and growth.

该协议的商业条款基于每千克的定价模型,大宗购买可享受折扣,反映了实现市场渗透和增长的战略方针。

Management Comments On The Agreement

管理层对协议的评论

Erick Ponce, CEO of ICAN and director of Xebra expressed his enthusiasm about the partnership. "This agreement exemplifies our commitment to Xebra and our desire to continue forward in growing the legal CBD products market in Mexico, and we look forward to supporting Desart MX in their endeavours," Ponce said.

ICAN首席执行官兼Xebra董事埃里克·庞塞表达了他对合作的热情。庞塞说:“该协议体现了我们对Xebra的承诺以及我们继续发展墨西哥合法CBD产品市场的愿望,我们期待着支持Desart MX的努力。”

Similarly, Rodrigo Gallardo, interim CEO of Xebra and Desart MX, emphasized the agreement's role in accelerating the commercialization process of CBD products in Mexico, bypassing the need for in-house CBD harvesting and extraction.

同样,Xebra和Desart MX的临时首席执行官罗德里戈·加拉多强调了该协议绕过内部CBD收获和提取的需求,在加速墨西哥CBD产品的商业化过程中的作用。

Both Xebra and ICAN view this partnership as a catalyst for strengthening their market positions and driving success in the burgeoning Mexican CBD industry.

Xebra和ICAN都将这种伙伴关系视为巩固其市场地位和推动蓬勃发展的墨西哥CBD行业取得成功的催化剂。

XBRAF Price Action

XBRAF 价格走势

XBRAF's shares were trading at $0.037 per share at the time of this writing around 11 AM ET Wednesday.

在撰写本文时,XBRAF的股票交易价格为每股0.037美元,美国东部时间周三上午11点左右。

Related News

相关新闻

  • Latest Cannabis Hires: Three New CEOs And More
  • Cannabis Opportunity: Xebra Brands Announces $1M Non-Brokered Private Placement Deal
  • 最新大麻招聘:三位新任首席执行官及更多
  • 大麻机会:Xebra Brands宣布100万美元的非经纪私募协议

Photo: Benzinga edit with Zero Degree 247 and MR.Yanukit on Shutterstock

照片:Benzinga 在 Shutterstock 上以 Zero Degree 247 剪辑和 Mr.Yanukit


The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.Get your tickets now on bzcannabis.com – Prices will increase very soon!

本辛加大麻资本会议将于2024年4月16日和17日在佛罗里达州好莱坞的新地点重返佛罗里达州。在外交官海滩度假村举行的为期两天的活动将为大小企业家提供交流、学习和成长的机会。以其引领潮流的能力和对大麻未来的影响而闻名,记住你的日历——这次会议是大麻界年度必去的活动。立即在bzcannabis.com上购买门票——价格很快就会上涨!

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发